A detailed history of Tower Research Capital LLC (Trc) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,021 shares of ORGO stock, worth $25,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,021
Previous 9,551 16.02%
Holding current value
$25,506
Previous $26,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.42 - $3.24 $3,702 - $4,957
-1,530 Reduced 16.02%
8,021 $22,000
Q2 2024

Aug 13, 2024

BUY
$2.28 - $3.03 $20,246 - $26,906
8,880 Added 1323.4%
9,551 $26,000
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $15,639 - $26,904
-5,992 Reduced 89.93%
671 $1,000
Q4 2023

Feb 13, 2024

BUY
$1.97 - $4.21 $6,372 - $13,619
3,235 Added 94.37%
6,663 $27,000
Q3 2023

Nov 14, 2023

SELL
$2.34 - $4.43 $3,486 - $6,600
-1,490 Reduced 30.3%
3,428 $10,000
Q2 2023

Aug 14, 2023

BUY
$1.9 - $4.3 $1,649 - $3,732
868 Added 21.43%
4,918 $16,000
Q1 2023

May 09, 2023

SELL
$1.89 - $2.93 $7,508 - $11,640
-3,973 Reduced 49.52%
4,050 $9,000
Q4 2022

Feb 10, 2023

SELL
$2.48 - $3.43 $186,734 - $258,265
-75,296 Reduced 90.37%
8,023 $22,000
Q3 2022

Nov 10, 2022

BUY
$3.14 - $6.43 $62,244 - $127,461
19,823 Added 31.22%
83,319 $270,000
Q2 2022

Aug 15, 2022

BUY
$4.74 - $8.15 $75,953 - $130,595
16,024 Added 33.75%
63,496 $310,000
Q1 2022

May 12, 2022

BUY
$6.47 - $9.57 $136,407 - $201,764
21,083 Added 79.89%
47,472 $362,000
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $53,831 - $80,568
5,968 Added 29.22%
26,389 $244,000
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $191,309 - $239,729
13,954 Added 215.77%
20,421 $291,000
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $56,069 - $87,298
3,758 Added 138.72%
6,467 $108,000
Q1 2021

May 17, 2021

BUY
$7.33 - $21.06 $4,537 - $13,036
619 Added 29.62%
2,709 $49,000
Q4 2020

Feb 16, 2021

SELL
$3.63 - $7.53 $70,530 - $146,307
-19,430 Reduced 90.29%
2,090 $16,000
Q3 2020

Nov 16, 2020

BUY
$3.29 - $4.58 $53,636 - $74,667
16,303 Added 312.5%
21,520 $82,000
Q2 2020

Aug 13, 2020

BUY
$2.86 - $4.61 $14,920 - $24,050
5,217 New
5,217 $20,000
Q1 2020

May 15, 2020

SELL
$2.92 - $5.31 $35,139 - $63,900
-12,034 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$4.7 - $8.11 $56,559 - $97,595
12,034 New
12,034 $58,000
Q3 2019

Nov 05, 2019

SELL
$3.57 - $8.09 $4,044 - $9,165
-1,133 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$6.58 - $8.69 $7,455 - $9,845
1,133 New
1,133 $9,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $416M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.